Journal of Pharma and Drug Innovation

Aim and Scope

The Journal of Pharma and Drug Innovation (JPDI) is devoted to promoting innovation and advancing high-quality research in the fields of pharmaceutical, biomedical, and drug development sciences. The journal publishes original research articles, comprehensive reviews, short communications, and case studies focusing on all aspects of drug discovery, formulation science, pharmacological evaluation, and therapeutic innovation.

JPDI emphasizes novel approaches in drug delivery systems, pharmaceutical chemistry, pharmacokinetics, regulatory science, and pharmaceutical biotechnology, with a vision to accelerate the translation of research findings into practical healthcare applications.

The journal welcomes interdisciplinary contributions that integrate pharmacy, medicine, chemistry, biotechnology, and life sciences to address emerging challenges in drug discovery and clinical therapeutics interested areas include:

  • Drug design, discovery, and development.
  • Advanced and targeted drug delivery systems.
  • Pharmacology and pharmacodynamics.
  • Pharmaceutical formulation and quality assurance.
  • Clinical pharmacology and therapeutic innovations
  • Natural product drug development and toxicological studies
  • Nanomedicine and biosimilar development
  • Regulatory science, GMP compliance, and pharmacovigilance
  • Rational drug use, healthcare policy, and patient safety

Through the dissemination of innovative, evidence-based research, JPDI aims to enhance pharmaceutical care, drug innovation, and public health outcomes. The journal encourages global collaboration among researchers, academicians, and industry professionals, providing a scholarly platform that supports the advancement of pharmaceutical sciences and modern drug innovation.